Key statistics
On Friday, Swedish Orphan Biovitrum AB (publ) (0MTD:LSE) closed at 407.80, -1.16% below its 52-week high of 412.60, set on Feb 11, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 412.20 |
|---|---|
| High | 407.80 |
| Low | 407.80 |
| Bid | -- |
| Offer | -- |
| Previous close | 410.20 |
| Average volume | 288.38k |
|---|---|
| Shares outstanding | 357.41m |
| Free float | 197.59m |
| P/E (TTM) | 314.31 |
| Market cap | 145.68bn SEK |
| EPS (TTM) | 1.30 SEK |
Data delayed at least 20 minutes, as of Feb 13 2026 17:34 GMT.
More ▼
- Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
- Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
